Marc Forth
Vermögen: 288 076 $ am 31.08.2026
Vermögen: 288 076 $ am 31.08.2026
Marc Forth is currently Chief Executive Officer & Director at Jeune Aesthetics, Inc. since 2025 and Director at AEON Biopharma, Inc. since 2025.
Formerly, Mr. Forth was Vice President-Sales & Marketing Urology at Allergan UC from 2011 to 2014.
Education includes undergraduate studies at Southern Methodist University and California State University-Fresno.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 973.231 ( 1,95 % ) | 288 076 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AEON BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 01.06.2023 |
Jeune Aesthetics, Inc.
Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Vorstandsvorsitzender | 07.04.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Southern Methodist University
Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California State University-Fresno
California State University-Fresno Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
AEON Biopharma, Inc.
AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets | Health Technology |
Jeune Aesthetics, Inc.
Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen